The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies
暂无分享,去创建一个
Daphne Koller | George M. Church | Jonathan Laserson | Gur Yaari | Uri Laserson | Michael S. Seaman | Galit Alter | Mehran Kardar | Arup K. Chakraborty | Dennis R. Burton | Pascal Poignard | Ian A. Wilson | Bryan Briney | Francois Vigneault | D. Koller | G. Church | A. Chakraborty | M. Kardar | D. Burton | I. Wilson | Uri Laserson | G. Alter | G. Yaari | S. Kleinstein | B. Briney | L. Walker | J. Julien | P. Poignard | Yi Liu | B. Simen | Jonathan Laserson | D. Sok | Francois Vigneault | K. Swiderek | M. Seaman | Shenshen Wang | Shenshen Wang | Devin Sok | P. Chan-Hui | A. Ramos | Bryan S. Briney | Khoa Le | Khoa Le | Jean-Philippe Julien | Laura M. Walker | Karen F. Saye | Alison E. Mahan | Elizabeth P. St. John | Yi Liu | Alejandra Ramos | Po-Ying Chan-Hui | Kristine Swiderek | Birgitte B. Simen | Alison Mahan | Stephen H. Kleinstein | Gur Yaari
[1] Richard T. Wyatt,et al. Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals , 2009, Nature.
[2] T. Kepler,et al. Analysis of a Clonal Lineage of HIV-1 Envelope V2/V3 Conformational Epitope-Specific Broadly Neutralizing Antibodies and Their Inferred Unmutated Common Ancestors , 2011, Journal of Virology.
[3] Guido Ferrari,et al. Vaccine induction of antibodies against a structurally heterogeneous site of immune pressure within HIV-1 envelope protein variable regions 1 and 2. , 2013, Immunity.
[4] Terri Wrin,et al. Human Immunodeficiency Virus Type 1 Elite Neutralizers: Individuals with Broad and Potent Neutralizing Activity Identified by Using a High-Throughput Neutralization Assay together with an Analytical Selection Algorithm , 2009, Journal of Virology.
[5] B. Haynes,et al. The Development of CD4 Binding Site Antibodies during HIV-1 Infection , 2012, Journal of Virology.
[6] Ron Unger,et al. IgTree: creating Immunoglobulin variable region gene lineage trees. , 2008, Journal of immunological methods.
[7] J. Mascola,et al. Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1 , 2010, Journal of Virology.
[8] Emden R. Gansner,et al. Graphviz and Dynagraph – Static and Dynamic Graph Drawing Tools , 2003 .
[9] T. Kepler,et al. Initial antibodies binding to HIV-1 gp41 in acutely infected subjects are polyreactive and highly mutated , 2011, The Journal of experimental medicine.
[10] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[11] Ping Zhu,et al. Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition , 2003, Science.
[12] Pham Phung,et al. Broad neutralization coverage of HIV by multiple highly potent antibodies , 2011, Nature.
[13] Dennis R. Burton,et al. Variable Loop Glycan Dependency of the Broad and Potent HIV-1-Neutralizing Antibodies PG9 and PG16 , 2010, Journal of Virology.
[14] T. Kepler,et al. H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination , 2011, PloS one.
[15] Dennis R. Burton,et al. A Limited Number of Antibody Specificities Mediate Broad and Potent Serum Neutralization in Selected HIV-1 Infected Individuals , 2010, PLoS pathogens.
[16] Tongqing Zhou,et al. Somatic Mutations of the Immunoglobulin Framework Are Generally Required for Broad and Potent HIV-1 Neutralization , 2013, Cell.
[17] M. Holder,et al. Hastings ratio of the LOCAL proposal used in Bayesian phylogenetics. , 2005, Systematic biology.
[18] Judea Pearl,et al. Reverend Bayes on Inference Engines: A Distributed Hierarchical Approach , 1982, AAAI.
[19] Eric Jones,et al. SciPy: Open Source Scientific Tools for Python , 2001 .
[20] D. Burton,et al. Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo , 2012, Proceedings of the National Academy of Sciences.
[21] K. Subbarao,et al. Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine. , 2010, The Journal of clinical investigation.
[22] P. Lipsky,et al. Secondary Immunization Generates Clonally Related Antigen-Specific Plasma Cells and Memory B Cells , 2010, The Journal of Immunology.
[23] Yan Liu,et al. A Potent and Broad Neutralizing Antibody Recognizes and Penetrates the HIV Glycan Shield , 2011, Science.
[24] John P. Huelsenbeck,et al. MrBayes 3: Bayesian phylogenetic inference under mixed models , 2003, Bioinform..
[25] J. Mascola,et al. N332-Directed Broadly Neutralizing Antibodies Use Diverse Modes of HIV-1 Recognition: Inferences from Heavy-Light Chain Complementation of Function , 2013, PloS one.
[26] D. Burton,et al. Rapid development of glycan-specific, broad, and potent anti–HIV-1 gp120 neutralizing antibodies in an R5 SIV/HIV chimeric virus infected macaque , 2011, Proceedings of the National Academy of Sciences.
[27] Randy J. Read,et al. Acta Crystallographica Section D Biological , 2003 .
[28] Jamie K. Scott,et al. Comparison of Antibody Repertoires Produced by HIV-1 Infection, Other Chronic and Acute Infections, and Systemic Autoimmune Disease , 2011, PloS one.
[29] Pham Phung,et al. Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target , 2009, Science.
[30] Baoshan Zhang,et al. Mining the antibodyome for HIV-1–neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains , 2013, Proceedings of the National Academy of Sciences.
[31] Susan Moir,et al. B cells in HIV infection and disease , 2009, Nature Reviews Immunology.
[32] James E. Crowe,et al. Location and length distribution of somatic hypermutation-associated DNA insertions and deletions reveals regions of antibody structural plasticity , 2012, Genes and Immunity.
[33] Xuesong Yu,et al. Factors Associated with the Development of Cross-Reactive Neutralizing Antibodies during Human Immunodeficiency Virus Type 1 Infection , 2008, Journal of Virology.
[34] John Steel,et al. Cross-neutralization of influenza A viruses mediated by a single antibody loop , 2012, Nature.
[35] X. Chen,et al. HIV-1 gp120 Vaccine Induces Affinity Maturation in both New and Persistent Antibody Clonal Lineages , 2012, Journal of Virology.
[36] L. Stamatatos,et al. Correction: Recombinant HIV Envelope Proteins Fail to Engage Germline Versions of Anti-CD4bs bNAbs , 2013, PLoS Pathogens.
[37] Paramvir S. Dehal,et al. FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments , 2010, PloS one.
[38] N. S. Laursen,et al. Highly Conserved Protective Epitopes on Influenza B Viruses , 2012, Science.
[39] Michel C Nussenzweig,et al. Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning. , 2008, Journal of immunological methods.
[40] W. K. Hastings,et al. Monte Carlo Sampling Methods Using Markov Chains and Their Applications , 1970 .
[41] J. Mascola,et al. Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies. , 2012, Immunity.
[42] Robert C. Edgar,et al. BIOINFORMATICS APPLICATIONS NOTE , 2001 .
[43] T. Kepler,et al. Envelope Deglycosylation Enhances Antigenicity of HIV-1 gp41 Epitopes for Both Broad Neutralizing Antibodies and Their Unmutated Ancestor Antibodies , 2011, PLoS pathogens.
[44] Young Do Kwon,et al. Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 , 2011, Nature.
[45] T. Kepler,et al. Differential Reactivity of Germ Line Allelic Variants of a Broadly Neutralizing HIV-1 Antibody to a gp41 Fusion Intermediate Conformation , 2011, Journal of Virology.
[46] L. Morris,et al. The Neutralization Breadth of HIV-1 Develops Incrementally over Four Years and Is Associated with CD4+ T Cell Decline and High Viral Load during Acute Infection , 2011, Journal of Virology.
[47] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[48] John D. Hunter,et al. Matplotlib: A 2D Graphics Environment , 2007, Computing in Science & Engineering.
[49] Radford M. Neal. Slice Sampling , 2003, The Annals of Statistics.
[50] Mario Roederer,et al. Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 , 2010, Science.
[51] Chaim A. Schramm,et al. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus , 2013, Nature.
[52] Mario Roederer,et al. Focused Evolution of HIV-1 Neutralizing Antibodies Revealed by Structures and Deep Sequencing , 2011, Science.
[53] Ryan McBride,et al. Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans , 2013, PLoS pathogens.
[54] J. Mascola,et al. High-Resolution Definition of Vaccine-Elicited B Cell Responses Against the HIV Primary Receptor Binding Site , 2012, Science Translational Medicine.
[55] Yan Liu,et al. Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120 , 2013, Nature Structural &Molecular Biology.
[56] Michael S. Seaman,et al. Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies , 2012, Proceedings of the National Academy of Sciences.
[57] Tongqing Zhou,et al. Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 , 2010, Science.